Grifols to acquire German healthcare company Biotest for €1.6bn
Spanish pharma company Grifols has agreed to acquire Tiancheng (Germany) Pharmaceutical, which holds nearly 90% stake of German publicly listed healthcare company Biotest. The deal ... Read More
Grifols phase 3 Covid-19 trial of hyperimmune globulins fails to meet objective
Spanish pharma company Grifols said that the phase 3 ITAC clinical trial assessing hyperimmune globulins as a treatment for patients hospitalized with Covid-19 has failed ... Read More
Grifols bags Xembify FDA approval for primary immunodeficiencies
Xembify FDA approval : Spanish pharma company Grifols has been granted approval from the US Food and Drug Administration (FDA) for Xembify (immune globulin subcutaneous, ... Read More